Using light-activated silver nanoparticles to fight antibiotic-resistant bacteria
Light-Activated Silver Nanoparticles to Eliminate Antibiotic Resistant Bacteria and Genes
This study is exploring a new way to fight tough infections caused by antibiotic-resistant bacteria using special light-activated particles, which could lead to better treatment options for patients who struggle with these hard-to-treat germs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of North Carolina Charlotte NIH-funded |
| Lab location | 1 site (Charlotte, United States) |
| Project ID | NIH-10881983 on NIH RePORTER |
What this research studies
This research investigates the use of light-activated silver nanoparticles to effectively eliminate antibiotic-resistant bacteria and the genes that confer resistance. By harnessing the unique properties of these nanoparticles, the study aims to develop a novel approach that combines antimicrobial activity with photodynamic inactivation. This method could potentially overcome the limitations of traditional antibiotics, which are often ineffective against resistant strains. Patients may benefit from new treatment options that can address infections caused by these hard-to-treat bacteria.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from infections caused by antibiotic-resistant bacteria.
Not a fit: Patients with infections that are not caused by antibiotic-resistant bacteria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that effectively combat antibiotic-resistant infections.
How similar studies have performed: Other research has shown promise in using nanomaterials for antimicrobial purposes, indicating potential success for this novel approach.
Where this research is happening
Charlotte, United States
- University of North Carolina Charlotte — Charlotte, United States (Active)
Researchers
- Principal investigator: Vivero-Escoto, Juan Luis — University of North Carolina Charlotte
- Study coordinator: Vivero-Escoto, Juan Luis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.